NCT04849637

Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 74 (actual)
• Sponsor: University of the Philippines · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a research that will investigate the safety and efficacy of virgin coconut oil (VCO) as an adjunctive therapy for Coronavirus Disease 2019 (COVID-19)

Detailed description

This study will be a randomized controlled trial among hospitalized COVID-19 patients, aged 18 years old and above, admitted at the Philippine General hospital. Patients will be grouped into the following: 1. Group receiving standard of care 2. Group receiving standard of care plus virgin coconut oil (15ml, 3x/day for 2 weeks) as adjunctive therapy. Patients will be observed as regards to primary outcomes such as recovery/resolution of symptoms and duration of hospital stay

Conditions

• Covid19

Interventions

Type	Name	Description
DRUG	Virgin Coconut Oil	Oral supplementation of virgin coconut oil to COVID-19 patients

Timeline

• Start date: 2020-10-22
• Primary completion: 2022-04-09
• Completion: 2022-04-09
• First posted: 2021-04-19
• Last updated: 2022-03-08

Locations

1 site across 1 country: Philippines